Serum Bone Minerals in Patients of Sickle Cell Anemia

Salah aldeen Abass  Ibrahim; AbdElkarim A.  Abdrabo

doi:10.52981/smlj.v9i1.2569

Salah aldeen Abass Ibrahim Department of clinical chemistry, Faculty of medical laboratory science, ALneelain university, Sudan
AbdElkarim A. Abdrabo Department of clinical chemistry, Faculty of medical laboratory science, ALneelain university, Sudan

DOI: https://doi.org/10.52981/smlj.v9i1.2569

Keywords: magnesium, calcium, phosphorous and Sickle Cell

Abstract

Introduction single nucleotide substitution A by T AT 17TH nucleotide of the 6th amino-acid Glutamic acid by valine in beta subunit of Hb (HbA) results in formation of sickle hemoglobin (HbS), Sickle bone syndrome is a public health problem to sicklers (disturbed serum bone minerals and bone density sickle cell crisis pain ). Because of genetic prevalence of sickle anaemia gene in Southern Sudan, sickle cell anaemia is a serious health issue and common cause of paediatrics admission at hospitals and the significance of measuring serum calcium, phosphorous and magnesium clarify the necessity to conduct this study.Which aimed to evaluate Ca, P and Mg Sudanese sicklers and correlate them to bone density and sickle cell crisis pain.

Methods: A descriptive Case control study conducted in Southern Darfur Nyala-city involving Sudanese sicklers 50 and age matched control group 50,Hb electrophoresis records and clinical data for patients with sickle disease (known cases of SCD) serum Ca, P and Mg and Albumin were estimated using fully automated chemistry analyzer ( Mindray BS-200)

Results: The results show normal magnesium levels with significant difference between serum magnesium levels among patients (2.43 (0.37),mg/dl) and controls (1.99 (0.47)mg/dl) p value 0.00, the mean serum calcium levels was significantly lower in the sickle cell disease group (8.4 (0.9 mg/dl)) compared to controls (9.4 (0.6) mg/dl) p value 0.00 . While the mean serum inorganic phosphorous was significantly higher in SCD group (6.6 (1.8) mg/dl) compared to control group (3.9 (0.82) mg/dl).

Conclusion: Normomagnesimia hyperphosphatemia and hypocalcaemia are observed in SCD compared to controls.

References

1-Kenneth Kaushansky et al Williams Hematology Newyork McGraw-Hill Education, 2016.
2- O.O.Oladipo ,E.O.Temiye, V.C.Ezeaka and P.Obomanu Serum magnesium, phosphate and calcium in Nigerian children with sickle cell disease wajm april-june, 2005 vol. 24 No. 2.
3-E. O. Ibe1*, A. C. J. Ezeoke2, I. Emeodi3, E. I. Akubugwo4, E. Elekwa4, M. C. Ugonabo5 and W. C. Ugbajah6. Electrolyte profile and prevalent causes of sickle cell crisis in Enugu, Nigeria. African Journal of Biochemistry Research Nov, 2009 Vol.3 (11), pp. 370-374.
4- Shahriar Zehtabchi, Richard Sinert, Stephan Rinnert,Betty Chang,Christian Heinis,Rachel A. Altura, Bella T. Altura, and Burton M. Altura. Serum Ionized Magnesium Levels and Ionized Calcium-to-Magnesium Ratios in Adult Patients With Sickle Cell Anemia. American Journal of Hematology (2004) 77:215–222 .
5-Adeboye H. Adewoye, Tai C. Chen, Qianli Ma, Lillian McMahon, Jeff Mathieu, Alan Malabanan, Martin H. Steinberg,and Michael F. Holick. Sickle cell bone disease: Response to vitamin D and calcium. American Journal of Hematology april 200883(4):271-274
6-Agbozo William. Serum magnesium levels in Ghanaian sickle cell disease patients
7-Yousif O. O. , Hassan M.K & Al-Naama l.M. Red Blood Cell and Serum Magnesium Levels Among Children and Adolescents With Sickle Cell Anemia. Biol Trace Elem Res (2018).
8-Olukoga AO,Ademoye HO, Erasmus RT, Adenoyin MA, Urinary magnesium excretion in steady state sickle cell anaemia. Acta haematol. 1993; 90:136-137.
9-Prasad A, Ortega J, Brewer GI, Oberleas D,Schoomaker EB, Trace elements in sickle cell disease JAMA 1976;235:2396-2398.
10-Akenami FOT, Aken،ova YA, Osifa BO, serum zinc, copper and Magnesium in sickle cell disease at Ibadan south western Nigeria Afr J Med med sci 1999; 28:137-139.
11-Nduka N, Kazem Y, Saleh B. variations in serum electrolytes and enzymes concentrations in patients with sickle cell disease J clin path 1995;48:648-651.
12-Nduka n, Ekeke GI, serum calcium and protein in haemoglobin ss patients, Folia haematol 1987;114: 508-511.
13-Muhammed S, Addae S, Suleiman S, Adzaku F, Annobil S, Kadduomi O , Richard J, Serum calcium , parathyroid hormone and vitamn D status in children and young adults with sickle cell disease , ann clin Biochem 1993;30:45-51.
14- Smith CE, Valika KS, Woo JE,O'Dennell JG,Gordon DL, Westerman MP, serum phosphate abnormality in sickle cell disease proceeding the society for experimental biology and medicine 1981;168:254-258.
15-Alharbi N, Annobil SH , Abbag F, Adzaku F , Basni W, renal reabsorption of phosphate in children with sickle cell anaemia, Am H nephrol 1999;19:552-554.
16- vitamin D deficiency and bone fragility in sickle cell disease, J, -B Arlet , J. Pouchor Handbook of of nutrition and diet therapy od bone diseases (2016) p 53- 66.
17-Ifeyinwa Osunkwo. An update on the recent literature on sickle cell bone disease Curr Opin Endocrinol Diabetes Obes. 2013 Dec; 20(6):539-46
18- Almeida. A. and Roberts. I, Bone involvement in sickle cell diseaseBritish Journal of Haematology,129, 482–490.
19-Aguilar C, Vichinsky E, Neumayr L. Bone and joint disease in sickle cell disease. Hematol Oncol Clin North Am. 2005 Oct;19(5):929-41.
`20- Buison AM1, Kawchak DA, Schall JI, Ohene-Frempong K, Stallings VA, Leonard MB, Zemel BS. Bone area and bone mineral content deficits in children with sickle cell disease. Pediatrics 2005 Oct; 116(4):943-9.
21-Lal A1, Fung EB, Pakbaz Z, Hackney-Stephens E, Vichinsky EP. Bone mineral density in children with sickle cell anemia. Pediatr Blood Cancer. 2006 Dec;47(7):901-6.
22-Soliman AT1, Bererhi H, Darwish A, Alzalabani MM, Wali Y, Ansari B. Decreased bone mineral density in prepubertal children with sickle cell disease: correlation with growth parameters, degree of siderosis and secretion of growth factors. J Trop Pediatr. 1998 Aug;44(4):194-8.
23- Bordbar MR, Haghpanah S, Zarei T1, Dabbaghmanesh MH, Omrani GR, Saki F. Evaluation of bone mineral density in children with sickle-cell anemia and its associated factors in the south of Iran: a case-control study. Arch Osteoporos. 2017 Dec;12(1):70.
24-Baldanzi G,Traina F, Francisco Marques Neto J, Oliveira Santos A,Dario Ramos C,Olalla Saad ST. Low bone mass density is associated with hemolysis in brazilian patients with sickle cell disease CLINICS 2011;66(5):801-805.
25- Aliyu, S., Rufa’I, A., A. Saidu, I., & M. Jajere, A. Musculoskeletal complications in sickle cell anemia patients: a ten-year retrospective review of hospital-based records (1991-2000) in two Nigerian hospitals. International Journal of Contemporary Pediatrics,2017 2(4), 329-334.
26- Adesina O, Brunson A, Keegan THM, Wun T. Osteonecrosis of the femoral head in sickle cell disease: prevalence, comorbidities, and surgical outcomes in California. Blood Advances. 2017;1(16):1287-1295.
27- Arlet JB1, Courbebaisse M, Chatellier G, Eladari D, Souberbielle JC, Friedlander G, de Montalembert M, Prié D, Pouchot J, Ribeil JA. Relationship between vitamin D deficiency and bone fragility in sickle cell disease:A cohort study of 56 adults Bone. 2013 Jan;52(1):206-11.
28- Sarrai M, Duroseau H, D'Augustine J, Moktan S, Bellevue R. Bone mass density in adults with sickle cell disease. Br J Haematol. 2007 Feb;136(4):666-72.
29- Patil PL, Rao BV. Case report: Sickle Cell Disease with Osteogenesis Imperfecta, J Assoc Physicians India. 2013 Jun;61(6):415-7.
22-Sabahelzain MM, Hamamy H. The ethnic distribution of sickle cell disease in Sudan. The Pan African Medical Journal. 2014;18:13. doi:10.11604/pamj.2014.18.13.3280.
30- Daak, A. A., Elsamani, E. , Ali, E. H., Mohamed, F. A., Abdel‐Rahman, M. E., Elderdery, A. Y., Talbot, O. , Kraft, P. , Ghebremeskel, K. , Elbashir, M. I. and Fawzi, W. (2016), Sickle cell disease in western Sudan: genetic epidemiology and predictors of know.